No abstract available
Keywords:
CHCHD10; CHCHD2; FMR1; Parkin (PARK2); fragile X syndrome; mitochondria; mitophagy; mtDNA.
Grants and funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by Grant-in-Aid for Scientific Research (24K02243) from the JSPS and AMED under Grant Number 23bm1423015h0001 in Japan.